FCMV

Foresite Capital Management V Portfolio holdings

AUM $80.7M
This Quarter Return
+9.78%
1 Year Return
-24.46%
3 Year Return
+66.81%
5 Year Return
10 Year Return
AUM
$322M
AUM Growth
+$322M
Cap. Flow
+$102M
Cap. Flow %
31.72%
Top 10 Hldgs %
89.88%
Holding
20
New
3
Increased
Reduced
Closed
3

Sector Composition

1 Healthcare 94.25%
2 Consumer Staples 2.48%
3 Financials 1.53%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SLGC
1
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$66M 20.51% +5,326,472 New +$66M
CGEM icon
2
Cullinan Oncology
CGEM
$445M
$61.6M 19.16% 2,731,410
IVVD icon
3
Invivyd
IVVD
$204M
$54.1M 16.81% +1,280,640 New +$54.1M
ACRS icon
4
Aclaris Therapeutics
ACRS
$209M
$22.6M 7.04% 1,258,243
KNTE
5
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$20.1M 6.26% 875,001
QSI icon
6
Quantum-Si Incorporated
QSI
$227M
$19.5M 6.07% 2,342,061
HLTH
7
DELISTED
Cue Health Inc. Common Stock
HLTH
$13.8M 4.29% +1,167,782 New +$13.8M
NRIX icon
8
Nurix Therapeutics
NRIX
$714M
$13.5M 4.2% 451,522
IRON icon
9
Disc Medicine
IRON
$2.07B
$9.84M 3.06% 2,435,125
HIMS icon
10
Hims & Hers Health
HIMS
$9.57B
$7.97M 2.48% 1,056,922
PHVS icon
11
Pharvaris
PHVS
$1.39B
$6.46M 2.01% 364,142
ME
12
DELISTED
23andMe Holding Co. Class A Common Stock
ME
$6.34M 1.97% 700,000
PRDS
13
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$6M 1.86% 602,500
PHICU
14
DELISTED
Population Health Investment Co., Inc. Unit
PHICU
$5.6M 1.74% 960,000
RACB
15
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$4.93M 1.53% 500,000
MLTX icon
16
MoonLake Immunotherapeutics
MLTX
$3.54B
$2.49M 0.77% 250,000
LHDX
17
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$760K 0.24% 485,000
ALXO icon
18
ALX Oncology
ALXO
$62.7M
-231,200 Closed -$12.6M
RLAY icon
19
Relay Therapeutics
RLAY
$619M
-400,000 Closed -$14.6M
TNGX icon
20
Tango Therapeutics
TNGX
$747M
-400,000 Closed -$4.55M